Page last updated: 2024-12-07

6-chloroindole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

6-Chloroindole is an important building block for the synthesis of various indole-based pharmaceuticals and natural products. It has been used as a starting material for the synthesis of various biologically active compounds, including anti-cancer agents, anti-inflammatory agents, and antibacterial agents. The compound is typically synthesized via electrophilic aromatic substitution of indole with chlorine. 6-chloroindole has been shown to exhibit a range of biological activities, including anti-proliferative activity, anti-oxidant activity, and antimicrobial activity. Research on 6-chloroindole is ongoing, with a focus on developing new therapeutic agents based on its structural framework. 6-chloroindole has also been shown to inhibit the growth of various cancer cell lines, suggesting its potential as a chemotherapeutic agent. It has also been found to exhibit anti-inflammatory activity, which could be beneficial for the treatment of inflammatory diseases. Moreover, 6-chloroindole has been reported to have antimicrobial activity, making it a potential candidate for the development of new antibiotics.'

Cross-References

ID SourceID
PubMed CID87111
CHEMBL ID511085
CHEBI ID80918
SCHEMBL ID75475
MeSH IDM000607099

Synonyms (43)

Synonym
AC-6211
EN300-39394
17422-33-2
nsc58083
nsc-58083
1h-indole, 6-chloro-
6-chloroindole ,
6-chloroindole, 99%
C-4240
STK503689
6-chloro-1h-indole
AKOS000265598
C17089
CHEMBL511085 ,
chebi:80918 ,
inchi=1/c8h6cln/c9-7-2-1-6-3-4-10-8(6)5-7/h1-5,10h
ytyimdrwptuahp-uhfffaoysa-
6-chlor-1h-indole
einecs 241-449-4
nsc 58083
AM803344
GEO-02877
FT-0621074
FT-0621075
FS-1732
bdbm50434114
SCHEMBL75475
mfcd00005681
SY002338
6-chloro-indole
6-chloro indole
6-chloro-1-h-indole
6-chloro-1h-indole #
DTXSID70169794
CS-W001973
Q27151419
BCP00061
SB34263
6-chloro-1h-indole aka 6-chloroindole
indole, 6-chloro-
M4E7MR63DA
HY-W001973
Z382723678
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
indolesAny compound containing an indole skeleton.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
ChymaseHomo sapiens (human)IC50 (µMol)340.00000.02602.639710.0000AID748040
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (10)

Processvia Protein(s)Taxonomy
angiotensin maturationChymaseHomo sapiens (human)
peptide metabolic processChymaseHomo sapiens (human)
extracellular matrix disassemblyChymaseHomo sapiens (human)
protein catabolic processChymaseHomo sapiens (human)
midbrain developmentChymaseHomo sapiens (human)
basement membrane disassemblyChymaseHomo sapiens (human)
positive regulation of angiogenesisChymaseHomo sapiens (human)
regulation of inflammatory responseChymaseHomo sapiens (human)
cellular response to glucose stimulusChymaseHomo sapiens (human)
cytokine precursor processingChymaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (4)

Processvia Protein(s)Taxonomy
endopeptidase activityChymaseHomo sapiens (human)
serine-type endopeptidase activityChymaseHomo sapiens (human)
serine-type peptidase activityChymaseHomo sapiens (human)
peptide bindingChymaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (8)

Processvia Protein(s)Taxonomy
collagen-containing extracellular matrixChymaseHomo sapiens (human)
extracellular regionChymaseHomo sapiens (human)
cytosolChymaseHomo sapiens (human)
secretory granuleChymaseHomo sapiens (human)
cytoplasmic ribonucleoprotein granuleChymaseHomo sapiens (human)
collagen-containing extracellular matrixChymaseHomo sapiens (human)
extracellular spaceChymaseHomo sapiens (human)
intracellular membrane-bounded organelleChymaseHomo sapiens (human)
cytoplasmChymaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID748040Inhibition of recombinant human chymase using bis(succinoyl-L-alanyl-L-prolyl-L-phenylalanylamide) as substrate after 1 hr by fluorescence assay2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Discovery of potent, selective chymase inhibitors via fragment linking strategies.
AID343398Octanol-water distribution coefficient, log D at pH 7.4 by shake-flask technique2008Journal of medicinal chemistry, Jul-10, Volume: 51, Issue:13
Toward prediction of alkane/water partition coefficients.
AID343680Hexadecane-water distribution coefficient, log D at pH 7.4 by shake-flask technique2008Journal of medicinal chemistry, Jul-10, Volume: 51, Issue:13
Toward prediction of alkane/water partition coefficients.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.91

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.91 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index5.08 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.91)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]